PHINIA (PHIN) VP adds 32 restricted shares via dividend reinvestment

Rhea-AI Filing Summary

PHINIA INC. vice president of operational excellence Christopher Gustanski received 32 shares of common stock as a grant under existing equity awards. The shares reflect restricted stock acquired through automatic dividend reinvestment on outstanding restricted stock. After this award, he directly holds 14,903 common shares, including 6,776 restricted shares.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Gustanski Christopher

Role VP, Operational Excellence

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	32	$0.00	--

Holdings After Transaction: Common Stock — 14,903 shares (Direct)

Footnotes (1)

1. Reflects shares of restricted stock acquired following the automatic reinvestment of dividends on outstanding restricted stock held on the dividend record date, as required by the terms of such awards. Includes 6,776 shares of restricted stock.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Gustanski Christopher

(Last) (First) (Middle)

3000 UNIVERSITY DRIVE

(Street)

AUBURN HILLS MICHIGAN 48326

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PHINIA INC. [ PHIN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	VP, Operational Excellence

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/20/2026		A		32(1)	A	$0	14,903(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects shares of restricted stock acquired following the automatic reinvestment of dividends on outstanding restricted stock held on the dividend record date, as required by the terms of such awards.

2. Includes 6,776 shares of restricted stock.

Remarks:

	/s/ Kelly A. Albin as attorney-in-fact for Christopher Gustanski	03/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did PHINIA (PHIN) insider Christopher Gustanski report on this Form 4?

Christopher Gustanski reported receiving 32 shares of PHINIA common stock. The acquisition was a grant tied to existing restricted stock awards, rather than an open-market purchase, and resulted from automatic dividend reinvestment on his outstanding restricted stock.

Is the PHINIA Form 4 transaction an open-market buy or a stock grant?

The PHINIA Form 4 shows a stock grant, not an open-market buy. Gustanski acquired 32 common shares at $0.00 per share through automatic dividend reinvestment on restricted stock, consistent with the terms of his existing equity awards.

How many PHINIA shares does Christopher Gustanski hold after this transaction?

After the transaction, Christopher Gustanski directly holds 14,903 PHINIA common shares. This total includes 6,776 shares of restricted stock, reflecting both previously awarded equity and the new 32-share grant from dividend reinvestment.

What explains the 32-share acquisition in PHINIA insider Gustanski’s Form 4?

The 32-share acquisition reflects restricted stock received through automatic reinvestment of dividends on outstanding restricted stock. The footnotes state this reinvestment is required under the terms of Gustanski’s existing restricted stock awards, making it a routine compensation-related adjustment.

Does the PHINIA Form 4 indicate any stock sales by Christopher Gustanski?

The Form 4 indicates no stock sales by Christopher Gustanski. It reports only an acquisition coded as an award (code A), tied to dividend reinvestment on restricted stock, with his direct holdings increasing to 14,903 PHINIA common shares after the transaction.